https://www.selleckchem.com/pr....oducts/paquinimod.ht
74 (95% confidence interval [CI] 0.70-0.79). The AUROC was 0.77 (95% CI 0.70-0.83) in patients undergoing UDCA monotherapy (n = 726). Finally, the AUROC of the modified UDCA Response Score using only data from the treatment start date was 0.80 (95% CI 0.70-0.9 in patients receiving a combination therapy of UDCA and bezafibrate (n = 16. Conclusion The validity of the UDCA Response Score was acceptable in Japanese patients; this score will be informative in patients treated with a combination therapy of UDCA and bezafibrate.Objecti
Aimer
Commentaire
Partagez
